Traditional Chinese herbal medicine in European Union: State of art, challenges, and future perspectives focusing on Italian market

被引:1
|
作者
Bilia, Anna Rita [1 ]
Ballerini, Rebecca [1 ]
Qu, Liping [2 ]
Wang, Mei [3 ,4 ,5 ]
机构
[1] Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Italy
[2] Chengdu Univ Tradit Chinese Med, State Key Lab Southwestern Chinese Med Resources, Chengdu 610037, Peoples R China
[3] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands
[4] Northwest Univ, Xian 710069, Peoples R China
[5] SU BioMed, NL-2333 BD Leiden, Netherlands
关键词
European and Italian market; food supplements; herbal medicinal products medical device; and cosmetic; traditional Chinese medicine; PRODUCTS; MONOGRAPH;
D O I
10.1016/j.chmed.2024.11.008
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Traditional Chinese herbal medicine (TCM) has been used in China for thousands of years as an integral part of the healthcare system.The use of botanical products deriving from plants from TCM has become very spread and rooted in European Union (EU), generating a manufacturing industry of pronounced size, in particular the segment of food supplements, but recently also medical devices and cosmetics based on plants from TCM, especially in Italy. Only seven Herbal Medicinal Products (HMP) based on plants from TCM are present in EU besides more than 100 monographs on TCM plants are present in the European Pharmacopoeia. Indeed, the number of herbal monographs of European Medicine Agency (EMA) which report the main data on safety and efficacy of medicinal plants from TCM are very limited and this could be a reason for the limited number of HMP based on herbal drugs used in TCM. It is clear that those botanicals based on TCM but not classified as HMP can represent a sort of "borderline" products. Very likely, they are present on the European market because of the simpler authorization when compared with HMP. Some examples of these categories (food supplements and medical devices) containing plants from TCM and marketed in Italy are reported in this review. Consequently, it is urgent the need to clarify their categorization, also fundamental for the consumer protection. It is imperative the establishment of EU quality standards and official registration for Chinese herbal medicinal products, even if they are marketed as food supplements, medicinal devices or cosmetics because the international quality standards International Organization for Standardization Technical Committee 249-Traditional Chinese Medicine (ISO/ TC249) can harmonize the quality control and promote the trading internationally. Governmental organizations together with companies producing TCM should work together to accelerate the legislation of laws pertaining to TCM, and generate an environment where TCM does not just continue to exist but truly develop. (c) 2024 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:3 / 18
页数:16
相关论文
共 50 条
  • [1] Traditional Chinese herbal medicine in European Union:State of art,challenges, and future perspectives focusing on Italian market
    Anna Rita Bilia
    Rebecca Ballerini
    Liping Qu
    Mei Wang
    Chinese Herbal Medicines, 2025, 17 (01) : 3 - 18
  • [2] Knowledge discovery in traditional Chinese medicine: State of the art and perspectives
    Feng, Yi
    Wu, Zhaohui
    Zhou, Xuezhong
    Zhou, Zhongmei
    Fan, Weiyu
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2006, 38 (03) : 219 - 236
  • [3] From Traditional Herbal Medicine to Rational Drug Discovery: Strategies, Challenges, and Future Perspectives
    Singh, Dev Bukhsh
    Pathak, Rajesh Kumar
    Rai, Dipti
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2022, 32 (02): : 147 - 159
  • [4] From Traditional Herbal Medicine to Rational Drug Discovery: Strategies, Challenges, and Future Perspectives
    Dev Bukhsh Singh
    Rajesh Kumar Pathak
    Dipti Rai
    Revista Brasileira de Farmacognosia, 2022, 32 : 147 - 159
  • [5] Traditional Chinese herbal injection: Current status and future perspectives
    Li, Haona
    Wang, Siwang
    Yue, Zhihua
    Ren, Xuequn
    Xia, Jielai
    FITOTERAPIA, 2018, 129 : 249 - 256
  • [6] Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges
    Li, Kexin
    Xiao, Kunmin
    Zhu, Shijie
    Wang, Yong
    Wang, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Herbal Medicinal Products versus Botanical-Food Supplements in the European market: State of Art and Perspectives
    Bilia, Anna Rita
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (01) : 125 - 131
  • [8] Diagnosis in traditional Chinese Medicine using Artificial Neural Networks: State-of-the-Art and perspectives
    Shi, Minghui
    Zhou, Changle
    ICNC 2007: THIRD INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 2, PROCEEDINGS, 2007, : 290 - +
  • [9] LIS state of the art and perspectives on the future in Italian university
    Faggiolani, Chiara
    AIB STUDI, 2013, 53 (02): : 95 - 103
  • [10] Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
    Huang, Yi
    Zhao, Yinglan
    Liu, Fang
    Liu, Songqing
    CURRENT DRUG TARGETS, 2015, 16 (13) : 1548 - 1562